Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: A comparative study with metformin

Chemico-Biological Interactions

Volumn 254, Issue , 2016, Pages 124-134

  Khan, Sabbir ^a   Jena, Gopabandhu ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Diabetes; Fat accumulation; Gluconeogenesis; HDAC inhibitor; Insulin resistance; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CHOLESTEROL; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HISTONE DEACETYLASE; HISTONE H3; LOW DENSITY LIPOPROTEIN; METFORMIN; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HISTONE; INSULIN; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CELL DAMAGE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; DYSLIPIDEMIA; ENZYME INHIBITION; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HISTONE ACETYLATION; HYPERTROPHY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID STORAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORGAN WEIGHT; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; RAT; WHITE ADIPOSE TISSUE; ACETYLATION; ADIPOSE TISSUE; ANALYSIS; ANIMAL; BLOOD; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; DYSLIPIDEMIAS; LIPID DIET; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ACETYLATION; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BUTYRIC ACID; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DYSLIPIDEMIAS; FORKHEAD BOX PROTEIN O1; GLUCONEOGENESIS; HEMOGLOBIN A, GLYCOSYLATED; HISTONE DEACETYLASES; HISTONES; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84974652543     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2016.06.007     Document Type: Article

References (45)

1. E. Nilsson, A. Matte, A. Perfilyev, V.D. de Mello, P. Kakela, J. Pihlajamaki, and C. Ling Epigenetic alterations in human liver from subjects with type 2 diabetes in parallel with reduced folate levels J. Clin. Endocrinol. Metab. 100 2015 E1491 E1501
2. T.X. Pham, and J. Lee Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases Nutrients 4 2012 1868 1886
3. S. Khan, G. Jena, and K. Tikoo Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat Exp. Mol. Pathol. 98 2015 230 239
4. M.E. Walsh, A. Bhattacharya, K. Sataranatarajan, R. Qaisar, L. Sloane, M.M. Rahman, M. Kinter, and H. Van Remmen The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging Aging Cell 2015 10.1111/acel.12387
5. J. Chen, N. Wang, M. Dong, M. Guo, Y. Zhao, Z. Zhuo, C. Zhang, X. Chi, Y. Pan, J. Jiang, H. Tang, J. Niu, D. Yang, Z. Li, X. Han, Q. Wang, and X. Chen The metabolic regulator histone deacetylase 9 contributes to glucose homeostasis abnormality induced by hepatitis c virus infection Diabetes 64 2015 4088 4098
6. M.M. Mihaylova, D.S. Vasquez, K. Ravnskjaer, P.D. Denechaud, R.T. Yu, J.G. Alvarez, M. Downes, R.M. Evans, M. Montminy, and R.J. Shaw Class iia histone deacetylases are hormone-activated regulators of foxo and mammalian glucose homeostasis Cell 145 2011 607 621
7. L. Larsen, M. Tonnesen, S.G. Ronn, J. Storling, S. Jorgensen, P. Mascagni, C.A. Dinarello, N. Billestrup, and T. Mandrup-Poulsen Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells Diabetologia 50 2007 779 789
8. S. Khan, and G. Jena Valproic acid improves glucose homeostasis by increasing beta-cell proliferation, function, and reducing its apoptosis through hdac inhibition in juvenile diabetic rat J. Biochem. Mol. Toxicol. 2016 10.1002/jbt.21807
9. J.C. Weems, B.A. Griesel, and A.L. Olson Class ii histone deacetylases downregulate glut4 transcription in response to increased camp signaling in cultured adipocytes and fasting mice Diabetes 61 2012 1404 1414
10. S. Raichur, S.H. Teh, K. Ohwaki, V. Gaur, Y.C. Long, M. Hargreaves, S.L. McGee, and J. Kusunoki Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells J. Mol. Endocrinol. 49 2012 203 211
11. K. Sharabi, C.D. Tavares, A.K. Rines, and P. Puigserver Molecular pathophysiology of hepatic glucose production Mol. Asp. Med. 2015 10.1016/j.mam.2015.09.003
12. A. Gastaldelli, S. Baldi, M. Pettiti, E. Toschi, S. Camastra, A. Natali, B.R. Landau, and E. Ferrannini Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study Diabetes 49 2000 1367 1373
13. H. Oiso, N. Furukawa, M. Suefuji, S. Shimoda, A. Ito, R. Furumai, J. Nakagawa, M. Yoshida, N. Nishino, and E. Araki The role of class i histone deacetylase (hdac) on gluconeogenesis in liver Biochem. Biophys. Res. Commun. 404 2011 166 172
14. S. Khan, S. Kumar, and G. Jena Valproic acid reduces insulin-resistance, fat deposition and foxo1-mediated gluconeogenesis in type-2 diabetic rat Biochimie 125 2016 42 52
15. X. Zhou, X.Y. Zeng, H. Wang, S. Li, E. Jo, C.C. Xue, M. Tan, J.C. Molero, and J.M. Ye Hepatic foxo1 acetylation is involved in oleanolic acid-induced memory of glycemic control: novel findings from study 2 PLoS One 9 2014 e107231
16. R.B. Canani, M.D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano Potential beneficial effects of butyrate in intestinal and extraintestinal diseases World J. Gastroenterol. 17 2011 1519 1528
17. Z. Gao, J. Yin, J. Zhang, R.E. Ward, R.J. Martin, M. Lefevre, W.T. Cefalu, and J. Ye Butyrate improves insulin sensitivity and increases energy expenditure in mice Diabetes 58 2009 1509 1517
18. D.R. Donohoe, L.B. Collins, A. Wali, R. Bigler, W. Sun, and S.J. Bultman The warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation Mol. Cell 48 2012 612 626
19. N. Li, M. Hatch, C.H. Wasserfall, M. Douglas-Escobar, M.A. Atkinson, D.A. Schatz, and J. Neu Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak? J. Pediatr. Gastroenterol. Nutr. 51 2010 414 417
20. R. Berni Canani, M. Di Costanzo, and L. Leone The epigenetic effects of butyrate: potential therapeutic implications for clinical practice Clin. Epigenet. 4 2012 4
21. J.W. Anderson, P. Baird, R.H. Davis Jr., S. Ferreri, M. Knudtson, A. Koraym, V. Waters, and C.L. Williams Health benefits of dietary fiber Nutr. Rev. 67 2009 188 205
22. J.W. Anderson, J.A. Zeigler, D.A. Deakins, T.L. Floore, D.W. Dillon, C.L. Wood, P.R. Oeltgen, and R.J. Whitley Metabolic effects of high-carbohydrate, high-fiber diets for insulin-dependent diabetic individuals Am. J. Clin. Nutr. 54 1991 936 943
23. M.A. Vinolo, H.G. Rodrigues, W.T. Festuccia, A.R. Crisma, V.S. Alves, A.R. Martins, C.L. Amaral, J. Fiamoncini, S.M. Hirabara, F.T. Sato, R.A. Fock, G. Malheiros, M.F. dos Santos, and R. Curi Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice Am. J. Physiol. Endocrinol. Metab. 303 2012 E272 E282
24. H.P. Li, X. Chen, and M.Q. Li Butyrate alleviates metabolic impairments and protects pancreatic beta cell function in pregnant mice with obesity Int. J. Clin. Exp. Pathol. 6 2013 1574 1584
25. G. Jakobsdottir, J. Xu, G. Molin, S. Ahrne, and M. Nyman High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects PLoS One 8 2013 e80476
26. H. Yadav, J.H. Lee, J. Lloyd, P. Walter, and S.G. Rane Beneficial metabolic effects of a probiotic via butyrate-induced glp-1 hormone secretion J. Biol. Chem. 288 2013 25088 25097
27. Y. Furusawa, Y. Obata, S. Fukuda, T.A. Endo, G. Nakato, D. Takahashi, Y. Nakanishi, C. Uetake, K. Kato, T. Kato, M. Takahashi, N.N. Fukuda, S. Murakami, E. Miyauchi, S. Hino, K. Atarashi, S. Onawa, Y. Fujimura, T. Lockett, J.M. Clarke, D.L. Topping, M. Tomita, S. Hori, O. Ohara, T. Morita, H. Koseki, J. Kikuchi, K. Honda, K. Hase, and H. Ohno Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T-cells Nature 504 2013 446 450
28. S. Khan, and G. Jena The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention Epigenomics 7 2015 669 680
29. G. Kanika, S. Khan, and G. Jena Sodium butyrate ameliorates l-arginine-induced pancreatitis and associated fibrosis in wistar rat: role of inflammation and nitrosative stress J. Biochem. Mol. Toxicol. 29 2015 349 359
30. S. Khan, and G. Jena Sodium butyrate, a hdac inhibitor ameliorates enos, inos and tgf-beta1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats Food Chem. Toxicol. 73 2014 127 139
31. S. Khan, and G.B. Jena Protective role of sodium butyrate, a hdac inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/erk mapk and apoptotic pathways: study in juvenile diabetic rat Chem. Biol. Interact. 213 2014 1 12
32. T.M. Henagan, B. Stefanska, Z. Fang, A.M. Navard, J. Ye, N.R. Lenard, and P.P. Devarshi Sodium butyrate epigenetically modulates high fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning Br. J. Pharmacol. 2015 10.1111/bph.13058
33. S. Khan, and G.B. Jena Effect of sodium valproate on the toxicity of cyclophosphamide in the testes of mice: influence of pre- and post-treatment schedule Toxicol. Int. 20 2013 68 76
34. S.D. Parlee, S.I. Lentz, H. Mori, and O.A. MacDougald Quantifying size and number of adipocytes in adipose tissue Methods Enzymol. 537 2014 93 122
35. S. Khan, and G. Jena Sodium valproate, a histone deacetylase inhibitor ameliorates cyclophosphamide-induced genotoxicity and cytotoxicity in the colon of mice J. Basic Clin. Physiol. Pharmacol. 27 2014 1 11
36. S. Khan, G. Jena, K. Tikoo, and V. Kumar Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of nf-kappab/inos signaling in diabetic rat Biochimie 110 2015 1 16
37. C.J. Jin, C. Sellmann, A.J. Engstler, D. Ziegenhardt, and I. Bergheim Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (nash) Br. J. Nutr. 114 2015 1745 1755
38. T.M. Henagan, B. Stefanska, Z. Fang, A.M. Navard, J. Ye, N.R. Lenard, and P.P. Devarshi Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning Br. J. Pharmacol. 172 2015 2782 2798
39. J. Lindstrom, M. Peltonen, J.G. Eriksson, A. Louheranta, M. Fogelholm, M. Uusitupa, and J. Tuomilehto High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the finnish diabetes prevention study Diabetologia 49 2006 912 920
40. M. Remely, E. Aumueller, C. Merold, S. Dworzak, B. Hippe, J. Zanner, A. Pointner, H. Brath, and A.G. Haslberger Effects of short chain fatty acid producing bacteria on epigenetic regulation of ffar3 in type 2 diabetes and obesity Gene 537 2014 85 92
41. R. Winkler, V. Benz, M. Clemenz, M. Bloch, A. Foryst-Ludwig, S. Wardat, N. Witte, M. Trappiel, P. Namsolleck, K. Mai, J. Spranger, G. Matthias, T. Roloff, O. Truee, K. Kappert, M. Schupp, P. Matthias, and U. Kintscher Histone deacetylase 6 (hdac6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis Diabetes 61 2012 513 523
42. D. D'Alessio The role of dysregulated glucagon secretion in type 2 diabetes Diabetes Obes. Metab. 13 Suppl. 1 2011 126 132
43. C. Haumaitre, O. Lenoir, and R. Scharfmann Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors Mol. Cell. Biol. 28 2008 6373 6383
44. F. De Vadder, P. Kovatcheva-Datchary, D. Goncalves, J. Vinera, C. Zitoun, A. Duchampt, F. Backhed, and G. Mithieux Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits Cell 156 2014 84 96
45. J. Duo, Y. Ma, G. Wang, X. Han, and C. Zhang Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line DNA Cell Biol. 32 2013 156 164